Sacituzumab,Trastuzumab deruxtecan,cetuximab,capivasertinib,Ipatasertib,alpelisib
Daiichi Sankyo,AstraZeneca,gilead sciences,eli lilly,genentech,Novartis
['love the', 'agent', 'tnbc']
love the honesty here re: #tnbc from ... "targeted agents: strong rationale, poor performance" so, what progress are we making? adcs - saci and tdxd, new agents coming #esmo22 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.